𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis

✍ Scribed by C. Santander; R. Moreno-Otero


Book ID
108606630
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
53 KB
Volume
35
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Impact of inflammatory bowel disease and
✍ Phunchai Charatcharoenwitthaya; Paul Angulo; Felicity B. Enders; Keith D. Lindor πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 282 KB πŸ‘ 2 views

A longitudinal, cohort study was performed to characterize the clinical features of patients with small-duct primary sclerosing cholangitis (PSC) occurring with and without inflammatory bowel disease (IBD) and to determine the influence of IBD and the effect of ursodeoxycholic acid (UDCA) therapy on